34 results
6-K
EX-99.1
SPRC
SciSparc Ltd
13 Dec 18
Therapix Biosciences Provides Update Regarding FSD Acquisition
6:03am
of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment
6-K
EX-99.1
SPRC
SciSparc Ltd
6 Jun 18
Therapix Biosciences Reports First Quarter 2018 Financial Results and Provides Business Update
4:55pm
the effect of the THX-130, proprietary ultra-low-dose THC, in a rodent model for cognitive impairment related to traumatic brain injury (TBI … ) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain. Please visit our website
6-K
EX-99.1
SPRC
SciSparc Ltd
21 Dec 18
Report of Foreign Private Issuer
8:11am
Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain. Please visit our website for more information
6-K
EX-99.1
SPRC
SciSparc Ltd
29 Nov 18
Report of Foreign Private Issuer
5:16pm
Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain. Please visit our website for more information
6-K
EX-99.1
SPRC
SciSparc Ltd
27 Nov 18
Therapix Biosciences Issues $1,500,000 Convertible Debenture
8:01am
), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment
6-K
EX-99.1
yyr2dor2v07w7p4 e60l
6 Dec 18
Therapix Biosciences Reports Third
6:18am
6-K
EX-99.1
r8igz3yy
24 Oct 18
Report of Foreign Private Issuer
6:45am
6-K
EX-99.1
v1g0 rloysox5ptq
9 Feb 21
SciSparc Initiates Commercial Production of its CannAmide™ Pills
8:36am
20-F
EX-4.3
wzxx8selpotdvh h78f9
1 May 17
Annual report (foreign)
12:00am
6-K
EX-10.3
0msm7
4 Apr 23
SciSparc completes the sale of a 49% interest in its Subsidiary that owns Wellution for $3 million
7:07am
6-K
EX-99.2
qsmmr4t 7qkahhpjdg
16 Aug 21
Interim Consolidated Financial Statements
12:00am
6-K
EX-99.3
ycwvqmty
30 Sep 22
SciSparc Enters Agreement to Acquire Wellution™, Top Seller of American Food Supplements and Cosmetics Brand on Amazon, for $20 million
7:27am
20-F
EX-4.12
i8d9yvj51qwk u8a
1 May 17
Annual report (foreign)
12:00am
424B2
qwzxvl
9 Aug 18
Prospectus for primary offering
11:19am
6-K
EX-99.1
wwbpkstn9atkkrf3yjq
28 Nov 18
Management’s Discussion and Analysis of Financial Condition and Results of Operations
6:27am
F-3
yvek0f 8afa
20 Jun 18
Shelf registration (foreign)
2:38pm
F-3/A
y3i7ki3 81hbabb
17 Jul 18
Shelf registration (foreign) (amended)
1:29pm
F-1
yicsy7g37srd9pspx
27 Feb 24
Registration statement (foreign)
4:15pm